Role of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review

Abstract

Polycystic ovary syndrome (PCOS) represents one of the most common endocrine disorders among women of reproductive age. It is often associated with hormonal imbalance, metabolic disturbances, and reproductive complications, which together contribute to an elevated risk of long-term cardiometabolic disorders. Limitations and side effects of conventional pharmacotherapies have prompted growing interest in nutrition-based adjunct strategies targeting core PCOS pathophysiology. To narratively synthesize mechanistic rationale and human clinical evidence on dietary seeds and selected nutraceuticals relevant to PCOS, with emphasis on metabolic and reproductive endpoints of interest to nutrition and obstetrics/gynecology practice. A targeted literature search was conducted in PubMed, Scopus, ScienceDirect, Wiley Online Library, Google Scholar, and ACS Publications for studies published up to December 2025. Search terms combined “polycystic ovary syndrome/PCOS” with seed-related terms (flaxseed, sesame, pumpkin, sunflower, chia, fenugreek, seed cycling) and nutraceuticals (myo‑inositol, D‑chiro‑inositol, omega‑3 fatty acids, curcumin, N‑acetylcysteine, coenzyme Q10, selenium, vitamin D, alpha‑lipoic acid). Among seeds, flaxseed trials and mixed-seed interventions (pumpkin/sunflower/sesame/flaxseed) have the most direct clinical data in PCOS and have been associated with improvements in insulin resistance indices (e.g., homeostatic model assessment of insulin resistance (HOMA-IR)), inflammatory markers, lipid profiles, and selected reproductive parameters (e.g., luteinizing hormone (LH)/follicle-stimulating hormone (FSH) ratio, ovarian morphology). However, heterogeneity in dosage, duration, and comparators limits firm conclusions. Pumpkin, sunflower, and sesame seeds may have potential mechanistic roles that are supported by human studies in related metabolic conditions, but PCOS-specific trials of individual seeds are still limited. Proposed “seed cycling” protocols have received attention, yet most clinical data are derived from mixed-seed supplementation studies or low-level evidence, such as case reports, and should be considered hypothesis-generating. Among nutraceuticals, inositols, omega‑3 fatty acids, curcumin, and N‑acetylcysteine show comparatively stronger clinical signals in PCOS, primarily for insulin sensitivity and selected endocrine or reproductive outcomes, whereas evidence for micronutrients such as selenium is more context-dependent. Dietary seeds and selected nutraceuticals represent promising adjuncts for PCOS management, especially for cardiometabolic risk modification, but the evidence base is limited by heterogeneity in PCOS phenotyping, interventions, and outcomes. Future trials should standardize diagnostic criteria, dosing, and clinically meaningful endpoints and explore which PCOS phenotypes benefit most from specific seed-based and nutraceutical strategies.

Introduction & Background

Polycystic ovary syndrome (PCOS) is among the most frequent endocrine disorders in women of reproductive age and is strongly associated with multiple cardiometabolic disturbances. Globally, the condition affects roughly 4-20% of women, underscoring its significance as a public-health concern [1,2]. PCOS is defined by the triad of hyperandogenism, anovulation, and polycystic ovarian morphology, but its clinical presentation extends far beyond the ovaries. Many women suffering from PCOS experience irregular menses, infertility, insulin resistance, obesity, dyslipidaemia, and chronic low-grade inflammation, all of which contribute to long-term risks for type 2 diabetes and cardiovascular disease [3,4].

Conventional management involves lifestyle changes with pharmacological therapy such as oral contraceptive pills, insulin-sensitizing agents, and anti-androgen drugs. While these approaches can reduce symptoms, they mostly do not address the underlying endocrine or metabolic disturbances and may be associated with adverse effects, including gastrointestinal discomfort, weight gain, and fatigue [5,6]. Consequently, there is growing interest in safer, sustainable, and nutrition-based strategies that address the pathophysiology of PCOS more holistically [7-9].

Among emerging approaches, dietary seeds have attracted attention for their dense concentration of bioactive compounds capable of influencing hormonal and metabolic pathways. Flax and sesame seeds provide lignans and phytoestrogens that bind to estrogen receptors and promote the conversion of stronger estrogens (estradiol) into weaker forms (estrone), thereby re-establishing a balanced estrogen-progesterone ratio [4,9,10]. Flaxseed lignans also enhance sex-hormone-binding globulin (SHBG) activity, helping to moderate circulating androgens, while sesame lignans contribute to luteal-phase hormonal balance. Pumpkin seeds, abundant in zinc, support the synthesis of follicle-stimulating and luteinizing hormones, facilitating ovulation; sunflower seeds, rich in vitamin E and selenium, aid progesterone production and protect ovarian tissues from oxidative injury [4,11]. Overall, these seeds appear to modulate key mechanisms related to PCOS, such as ovarian steroidogenesis, gonadotropin signaling, insulin sensitivity, and oxidative stress [4,9,10].

Beyond seeds, a broader range of nutraceutical compounds has been explored for their potential to improve metabolic and reproductive dysfunction in PCOS. Among the most widely studied are the inositol isomers myo-inositol (MI) and D-chiro-inositol (DCI), which enhance insulin sensitivity and help re-establish ovulatory cycles [12,13]. Omega-3 fatty acids improve lipid metabolism and reduce inflammatory activity [14,15], whereas vitamin D and other micronutrients regulate reproductive hormones and glucose homeostasis [16]. Increasing evidence also points to the benefits of curcumin, a polyphenolic compound from turmeric, which down-regulates inflammatory mediators and oxidative stress, thereby improving insulin action [17].

Likewise, resveratrol, N-acetylcysteine (NAC), and coenzyme Q10 have demonstrated antioxidant and anti-inflammatory properties that may improve androgen balance and ovarian performance [18,19].

Although individual studies suggest promising outcomes, existing evidence remains fragmented. Variability in study design, dosage, treatment duration, and clinical endpoints limits clear conclusions regarding the comparative effectiveness of these interventions. A systematic integration of current findings is therefore needed to clarify the mechanistic pathways, therapeutic efficacy, and practical application of seeds and nutraceuticals in PCOS management. Accordingly, this narrative review aims to critically assess and synthesize the available literature on the role of seeds and nutraceutical compounds in the management of PCOS, emphasizing their biochemical mechanisms, clinical outcomes, and potential incorporation into comprehensive dietary and therapeutic frameworks for women with the syndrome.

Review

Methodology

A comprehensive electronic search was carried out across PubMed, Scopus, Science Direct, the Willey online library, Google Scholar and ACS publications were explored extensively using keywords including Polycystic Ovary Syndrome”, “PCOS”, “seeds”, “flaxseed”, “fenugreek”, “chia seed”, “sesame seed”, “pumpkin seeds”, “bioactive compounds”, “nutraceutical”, “functional foods”, ”, “antioxidants”, “essential fatty acids”, “fibre”, “omega-3 fatty acids”, “vitamins”, and “minerals”. Studies were included if they met the following criteria: (a) women diagnosed with PCOS; (b) assessed the effects of seeds or nutraceutical compounds on metabolic, hormonal, or reproductive outcomes; (c) were randomized controlled trials (RCTs), clinical trials, or observational studies; and (d) were peer-reviewed full-text articles. Exclusion criteria included studies on pharmacological treatments only or lacking PCOS-specific outcomes. Although this is a narrative review, we used a systematic search strategy (Figure 1) adopted from Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [20].

Figure 1 outlines the selection process for studies retrieved from PubMed, Scopus, and Google Scholar (2000-2025). A total of 218 records were identified, and 28 studies were included in the final narrative synthesis after removing duplicates and irrelevant articles. Both experimental (human, animal, and in vitro) and review studies were considered, focusing on seed-derived and nutraceutical interventions with relevance to PCOS outcomes. Table 1 gives a summary of these studies.

Flaxseeds

What is the role of flaxseed in PCOS? Flaxseed contains dense concentrations of omega-3 fatty acids and lignans that help regulate your menstrual cycle. Clinical trials show that 30g of daily flaxseed powder increases follicle-stimulating hormone (FSH) profiles, lowers androgen availability via increased SHBG, and actively reduces systemic metabolic insulin resistance.

Flaxseed (Linum usitatissimum) has emerged as a promising functional food for managing PCOS, owing to its rich content of lignans (phytoestrogens), α-linolenic acid (omega-3 fatty acid), fiber, and phytosterols such as β-sitosterol and stigmasterol [23]. Human clinical trials demonstrate that flaxseed supplementation significantly improves reproductive endocrine function in women with PCOS. In a randomized controlled trial, Najdgholami et al. [21] reported that daily flaxseed intake for 12 weeks led to a significant increase in follicle-stimulating hormone (FSH) and a reduction in the luteinizing hormone (LH)/FSH ratio, suggesting restoration of ovulatory function and hormonal balance. Similarly, Farzana et al. [22] observed that flaxseed supplementation decreased ovarian volume and follicle number while improving menstrual cycle regularity. Metabolic outcomes have also been favourably influenced by flaxseed intake. In a clinical trial, Haidari et al. [5] found that 30 g/day of ground flaxseed combined with lifestyle modification resulted in a reduction in insulin resistance (homeostatic model assessment of insulin resistance (HOMA-IR)), improvement in lipid profile, and lowered inflammatory markers (high-sensitivity C-reactive protein (hsCRP)) compared to controls. These results are supported by Rasheed et al. [9], who demonstrated that a mixed-seed regimen including flaxseed, sunflower seeds, pumpkin seeds, and sesame seeds improved insulin sensitivity and reduced hormonal disturbances in women with PCOS. A recent in silico and in vitro study suggested that flaxseed bioactives can influence insulin receptor signalling and inflammatory cascades relevant to PCOS pathophysiology. Furthermore, Zafar et al. [11] highlighted flaxseed's role within seed cycling protocols, particularly during the follicular phase, where its phytoestrogenic lignans support estrogen modulation and cycle regularity.

Pumpkin seeds

How do pumpkin seeds alleviate PCOS symptoms? Pumpkin seeds are premium dietary sources of zinc and magnesium. Zinc functions as a primary biochemical cofactor for estrogen-progesterone balancing and reproductive ovulation regulation, while active magnesium down-regulates metabolic insulin resistance, reducing androgen overproduction to handle chronic cycle bloating and acne trends naturally.

Pumpkin seeds (Cucurbita pepo) are nutritionally dense seeds rich in zinc, magnesium, unsaturated fatty acids (omega-3 and omega-6), phytosterols (β-sitosterol, stigmasterol), antioxidants (tocopherols, carotenoids, polyphenols), and amino acids such as arginine and tryptophan, all of which exert diverse metabolic and endocrine effects relevant to the management of PCOS [45,46]. Zinc acts as a crucial cofactor for numerous enzymes involved in insulin synthesis, glucose metabolism, and steroid hormone regulation, while magnesium contributes to insulin receptor signaling and oxidative stress reduction, both critical for alleviating insulin resistance and hyperandrogenism commonly observed in PCOS [46,47]. The unsaturated fatty acids (ω-3 and ω-6) and phytosterols in pumpkin seeds enhance membrane fluidity, modulate inflammatory mediator synthesis, and influence adipokine and androgen receptor signaling, thereby supporting lipid regulation, estrogen metabolism, and ovarian function [45,47]. Antioxidant compounds such as tocopherols, carotenoids, and polyphenols scavenge reactive oxygen species and limit lipid peroxidation, which can otherwise impair follicular maturation and insulin sensitivity [45].

Additionally, amino acids like arginine promote nitric oxide synthesis, improving vascular perfusion and metabolic homeostasis, while tryptophan contributes to neuroendocrine regulation and stress response, both relevant to PCOS symptom control [46]. In integrative seed-cycling protocols, Zafar et al. found that pumpkin seeds are typically consumed during the follicular phase, paired with flaxseed, to promote estrogen metabolism, ovulatory preparation, and cycle regularity [11]. Clinical evidence from a randomized controlled trial by Rasheed et al. found that combined seeds (pumpkin, flax, sesame, sunflower) have shown a significant improvement in insulin sensitivity, lipid profile, and hormonal balance, including reductions in LH/FSH ratio and androgen levels [9]. Emerging reports and case studies also suggest that regular pumpkin seed intake contributes to lower testosterone, improved glucose-insulin ratio, and better BMI control in women with PCOS, likely through the synergistic actions of its micronutrients and phytochemicals [24,47].

Sunflower seeds

Why are sunflower seeds recommended for cycle balance? Sunflower seeds provide natural Vitamin E and trace organic selenium elements. Vitamin E serves as a potent antioxidant that limits follicular lipid peroxidation and eases primary menstrual discomfort, while selenium cofactors upregulate protective glutathione processes to support progesterone generation during the luteal phase.

Sunflower seeds (Helianthus annuus) are a nutrient-dense source of vitamin E, selenium, healthy unsaturated fatty acids, and trace zinc, making them relevant to nutritional strategies for PCOS due to their potential to influence oxidative stress, inflammation, and reproductive hormone balance. Oxidative stress is a recognized contributor to the pathophysiology of PCOS, promoting insulin resistance, chronic inflammation, and ovarian dysfunction [26,48]. Vitamin E, the predominant antioxidant in sunflower seeds, has been evaluated in randomized controlled clinical trials primarily in the context of menstrual health: supplementation studies demonstrate that vitamin E significantly reduces pain severity and duration in primary dysmenorrhea, an outcome linked to its inhibition of prostaglandin synthesis and attenuation of lipid peroxidation [27,49]. Furthermore, systematic reviews suggest that vitamin E intake, whether as a supplement or from food sources, can improve lipid profiles, insulin resistance, reproductive hormone ratios, and oxidative stress markers in women with PCOS, reinforcing the mechanistic relevance of sunflower seed antioxidants [50].

Selenium, another micronutrient abundant in sunflower seeds, acts as a cofactor for glutathione peroxidase and other redox-regulating enzymes; clinical evidence indicates that selenium supplementation may modulate inflammatory and oxidative biomarkers in women with PCOS, although results are variable and context-dependent [25]. Healthy unsaturated fats in sunflower seeds also align with evidence showing that dietary vitamin E and omega-3 fatty acids improve insulin sensitivity, lipid metabolism, and inflammatory gene expression (e.g., peroxisome proliferator-activated receptor gamma (PPAR-γ), interleukin 8 (IL-8), tumor necrosis factor alpha (TNF-α)) in PCOS cohorts [51]. In integrative approaches such as seed-cycling protocols, sunflower seeds are recommended during the luteal phase to support progesterone production, antioxidant defense, and menstrual comfort via their vitamin E and selenium content [11,52]. While direct randomized clinical trials investigating sole sunflower seed intake in PCOS are not yet published, interventional seed-cycling studies that include sunflower seeds alongside flaxseed, pumpkin seed and sesame seed report improved hormonal profiles, insulin sensitivity and ovarian morphology in women with PCOS, implying potential benefits from the bioactive constituents of sunflower seeds when consumed as part of a structured dietary intervention [9].

Sesame seeds

What are the therapeutic properties of sesame seeds for hormones? Sesame seeds contain unique sesamin and sesamolin lignans that exert phytoestrogen-like activity. These bioactive compounds help regulate luteal phase estrogen clearance, suppress chronic metabolic inflammation via down-regulated NF-kB path arrays, and significantly lower blood glucose and total cholesterol markers.

Sesame seeds (Sesamum indicum) are nutrient-dense seeds providing lignans (sesamin, sesamolin), vitamin E, calcium, zinc, and unsaturated fatty acids, all of which contribute to antioxidant, anti-inflammatory, and potential hormone-modulating effects relevant to polycystic ovaries [53]. The major sesame lignans sesamin and sesamolin exhibit phytoestrogen-like activity, influencing estrogen and progesterone metabolism through modulation of steroidogenic enzymes and hepatic estrogen clearance [54,55]. Mechanistically, these lignans activate PPAR-α and AMP-activated protein kinase (AMPK), enhance fatty acid oxidation, suppress nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB)-mediated inflammation, and increase antioxidant enzyme activity, thereby improving lipid and glucose metabolism [55,56]. Clinical studies and systematic reviews in metabolic and cardiovascular contexts have demonstrated that sesame consumption or sesamin supplementation can significantly reduce total cholesterol, low-density lipoprotein cholesterol (LDL-C), and systolic blood pressure and improve oxidative stress and inflammatory markers. It has also been found that sesame intake led to reductions in fasting glucose, glycated hemoglobin (HbA1c), and C-reactive protein (CRP), supporting its value in metabolic-syndrome-type states that overlap with PCOS [56-58].

Although direct randomized controlled trials on isolated sesame seed intake in women with PCOS are limited, emerging interventional evidence from combined-seed protocols incorporating sesame alongside flaxseed, sunflower, and pumpkin seeds shows promising effects. In a 12-week clinical trial, women with PCOS receiving a daily mixed-seed supplement (15 g of each seed powder/day) experienced improvements in FSH, LH, and progesterone levels, reduced ovarian volume, follicle number, better BMI, and insulin sensitivity compared with controls [9]. These findings align with the seed-cycling framework in which sesame seeds are consumed during the luteal phase together with sunflower seeds to support progesterone production and menstrual comfort [11]. Beyond reproductive endpoints, both animal and human studies indicate that sesame seed and lignan consumption enhances antioxidant capacity, improves hepatic lipid metabolism, and lowers oxidative stress biomarkers, all of which are beneficial in addressing the metabolic inflammation and insulin resistance characteristic of PCOS [44,58].

Finger millet (ragi)

How does ragi millet benefit women with PCOS insulin resistance? Ragi finger millet contains extensive prebiotic dietary fiber and unique polyphenols. These compounds actively slow carbohydrate digestion and prevent sudden postprandial insulin spikes, helping manage fasting blood sugar levels and improving weight-management protocols.

Finger millet (Eleusine coracana), commonly known as ragi, is a nutrient-dense cereal and a recognized nutraceutical compound rich in dietary fiber (~15-20%), polyphenols, flavonoids, and minerals such as calcium and iron, which contribute to its potential metabolic benefits, including modulation of glucose metabolism and weight management [59]. The dietary fiber and phenolic compounds in ragi slow carbohydrate digestion and glucose absorption, leading to lower postprandial glycemic responses and attenuated insulin spike effects highly relevant to improving insulin sensitivity in women with PCOS, where insulin resistance is a central pathological feature [60]. It was also observed that regular finger millet consumption significantly lowers fasting and postprandial blood glucose and reduces HbA1c compared with equivalent refined grain diets, indicating that millet-based diets may favorably influence glucose homeostasis in metabolic disorders relevant to PCOS [60,61].

Beyond glycaemic control, the prebiotic fiber and polyphenols in ragi are metabolized by gut microbiota into short-chain fatty acids (SCFAs) such as butyrate and propionate, which improve insulin sensitivity, reduce systemic inflammation, and modulate lipid metabolism pathways commonly dysregulated in PCOS [62]. The high fiber content of finger millet also enhances satiety and reduces caloric intake, supporting weight management, a key lifestyle strategy for improving insulin resistance and reproductive outcomes in PCOS [63,64].

Indian gooseberry (amla)

Can Indian gooseberry improve metabolic markers in PCOS? Yes. Indian gooseberry (Amla) is highly saturated with natural vitamin C and polyphenols. Controlled human clinical data verify that amla fruit components lower fasting blood glucose, decrease systemic serum triglycerides, and significantly raise protective high-density lipoprotein (HDL) levels.

Amla (Emblica officinalis), a recognized nutraceutical compound, is rich in vitamin C, polyphenols, and flavonoids that confer antioxidant and anti-inflammatory effects relevant to metabolic disorders such as PCOS [65]. Clinical evidence from a systematic review and meta-analysis demonstrates that amla supplementation leads to significant reductions in fasting blood glucose, LDL-C, total cholesterol, and triglycerides and increases in high-density lipoprotein cholesterol (HDL-C) in adults with cardiometabolic risk factors, supporting its role in improving insulin sensitivity and lipid metabolism [66]. In a randomized controlled trial, Akhtar et al. (2011) reported that in normal and type 2 diabetic volunteers, the daily intake of amla fruit powder for 21 days significantly lowered fasting and postprandial blood glucose and improved total cholesterol and triglyceride levels compared with baseline [28]. Another clinical study by Usharani et al (2019) showed that a standardized aqueous extract of amla significantly improved lipid profile, endothelial function, markers of oxidative stress, and systemic inflammation in subjects with metabolic syndrome compared with placebo [29].

Although direct randomized controlled trials specifically in women with PCOS are currently limited, the existing human clinical evidence supports that amla positively influences glycemic control, lipid profiles, and inflammation, key aspects of PCOS pathophysiology [66]. In addition, mechanistic and preclinical research further indicates that amla’s bioactive phytochemicals enhance antioxidant defenses and may modulate pathways involved in insulin resistance and dyslipidemia, although these mechanisms require further confirmation in PCOS populations [67]. Taken together, clinical and mechanistic evidence support the potential of amla as a nutraceutical agent for improving metabolic parameters commonly impaired in PCOS.

Dates

Are dates safe to consume for individuals with PCOS? Yes. When consumed in moderation, dates are safe and metabolically beneficial. Their rich dietary fiber profile balances natural sugar delivery, preventing glycemic spikes, while active quercetin and luteolin antioxidants enhance antioxidant enzyme profiles to protect cellular frameworks.

Dates (Phoenix dactylifera) are nutrient-rich fruits high in natural sugars combined with dietary fiber, potassium, polyphenols, and flavonoid antioxidants, which help slow carbohydrate absorption and modulate oxidative stress, making them a functional food with potential metabolic benefits [68]. Systematic reviews and clinical trials indicate that moderate date consumption does not worsen glycemic control and may improve lipid metabolism, including reductions in total cholesterol and LDL cholesterol and increases in HDL cholesterol in adults with metabolic risk factors [69]. In type 2 diabetes patients, daily modest date intake (three dates per day) did not adversely affect fasting glucose or HbA1c compared with other snacks, confirming glycemic safety over 16-week intervention periods [30]. Similarly, Ajwa date pit powder supplementation in adults with hyperlipidemia showed reductions in body weight, BMI, fat mass, total cholesterol, and LDL, suggesting beneficial effects on obesity and lipid parameters, which are commonly associated with PCOS [70]. These human studies support that dates are metabolically safe and may contribute to improved glycemic and lipid regulation in conditions related to insulin resistance.

Further studies support the metabolic benefits of date bioactives. Dates and their seeds are rich in polyphenols and flavonoids, particularly phenolic acids, quercetin, and luteolin, that exhibit strong antioxidant and anti-inflammatory activity, enhance endogenous antioxidant enzymes such as superoxide dismutase and catalase, and reduce oxidative stress markers involved in metabolic dysregulation seen in PCOS [71]. In hypercholesterolemic rat models, Ajwa date extracts significantly lowered total cholesterol, LDL, very-low-density lipoprotein (VLDL), and triglycerides while increasing HDL, demonstrating the lipid-modulating potential of date-derived fiber and bioactive compounds [72]. Moreover, in vitro studies with polyphenol-rich date seed extracts show increased glucose uptake, upregulation of glucose transporter type 4 (GLUT-4) and AMPK signaling, and inhibition of adipocyte differentiation mechanisms that support improved insulin sensitivity and weight regulation relevant to PCOS management [73].

Jaggery

Should jaggery be used as a sugar substitute in PCOS diets? Jaggery contains trace elements like iron and potassium, but it remains a rapidly digestible carbohydrate. To minimize postprandial blood sugar spikes, individuals with PCOS should use jaggery sparingly and pair it with fiber or protein to slow absorption.

Jaggery is an unrefined sweetener from sugarcane or palm sap, retaining trace minerals such as iron, calcium, magnesium, potassium, and antioxidant polyphenols, which give it higher nutritive and functional value than refined sugar [74]. Analytical studies show that jaggery has higher phenolic content and antioxidant activity, suggesting potential free radical scavenging properties that may influence oxidative stress, a factor implicated in insulin resistance and metabolic disturbances in PCOS [75].

While jaggery contains antioxidants, minerals, and other micronutrients that contribute to its nutraceutical profile, these compounds exist alongside a high concentration of rapidly digestible sugars, meaning that the nutrient benefits are unlikely to counteract its impact on postprandial glycemia unless intake is limited [76]. Dietary fiber has been shown to slow glucose absorption and reduce rapid postprandial glucose rises when carbohydrates are ingested, likely due to increased intestinal viscosity and delayed gastric emptying [77]. Similarly, higher protein intake can alter postprandial glucose responses and support more stable glucose levels when combined with carbohydrate intake [78,79]. Thus, in PCOS diets, jaggery should be consumed in small amounts and ideally paired with fiber-rich or protein-rich foods that slow carbohydrate digestion and absorption.

Inositol (myo‑inositol and D‑chiro‑inositol)

What is the ideal inositol ratio for PCOS management? Clinical research supports a physiological 40:1 ratio of Myo-Inositol to D-Chiro-Inositol. This configuration mimics endogenous plasma ratios, optimizes second-messenger insulin signaling pathways, and systematically lowers circulating free testosterone to re-establish ovulatory menses regularity.

Inositols, particularly myo‑inositol (MI) and D‑chiro‑inositol (DCI), are sugar‑like compounds considered nutraceuticals that support insulin signalling and ovarian function in women with PCOS. Meta‑analyses of randomized controlled trials show MI reduces fasting insulin, while MI + DCI in a physiological 40:1 ratio improves menstrual regulation, ovulation rates, and endocrine markers in PCOS patients, with effects similar to or complementary to metformin for metabolic and reproductive parameters. Trials also demonstrate significant improvements in ovarian volume and quality of life measures with MI + DCI supplementation compared with standard therapy alone, supporting its role in enhancing insulin sensitivity and reproductive outcomes [34].

Curcumin

Does curcumin reduce insulin resistance in PCOS? Yes. Curcumin effectively mitigates glycemic imbalances. Longitudinal clinical trials prove that daily curcumin intake lowers HOMA-IR scales, reduces body mass index variations, and acts synergistically with insulin-sensitizing agents to improve blood profiles.

Curcumin, the main polyphenolic compound in turmeric, has demonstrated antioxidant and anti‑inflammatory effects that translate into improved metabolic parameters in women with polycystic ovary syndrome [80]. Randomized clinical trials show that curcumin supplementation for 12 weeks significantly reduces fasting glucose, fasting insulin, and HOMA‑IR, and improves insulin sensitivity compared with placebo, indicating enhanced glycemic control and insulin resistance [32,33]. Additionally, in a randomized controlled trial (RCT) of women with PCOS receiving metformin, adding curcumin was associated with greater reductions in fasting insulin and HOMA‑IR and improvements in HDL cholesterol and total cholesterol than metformin alone [81]. Other randomised control trial reports that curcumin alone leads to better serum insulin levels and insulin sensitivity indices versus placebo, although effects on some lipid markers and hyperandrogenism vary [31]. Systematic reviews and meta‑analyses of these RCTs confirm curcumin’s benefits on glycemic control (fasting glucose, insulin, HOMA‑IR) and select cardiometabolic risk factors in PCOS, supporting its use as a nutraceutical adjunct.

Omega‑3 fatty acids

What are the benefits of Omega-3 for PCOS cardiometabolic risks? Omega-3 fatty acids significantly alter systemic lipid profiles. Documented medical endpoints verify that targeted EPA and DHA consumption lowers serum triglycerides, reduces low-density lipoprotein (LDL), and improves overall lean body composition ratios.

Omega‑3 polyunsaturated fatty acids (PUFAs), particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) from fish oil or plant sources, are supported by systematic reviews and meta-analyses of randomized controlled trials as effective nutraceuticals for improving metabolic status with significant reductions in insulin resistance and total cholesterol in women with polycystic ovary syndrome. Supplementation with omega‑3 fatty acids improves lipid metabolism and reduce inflammatory activity [14,15], whereas vitamin D and other micronutrients regulate reproductive hormones and glucose homeostasis [16]. Increasing evidence also points to the benefits of curcumin, a polyphenolic compound from turmeric, which down-regulates inflammatory mediators and oxidative stress, thereby improving insulin action [17].

Biochemical Summary of Trace Elements

Likewise, resveratrol, N-acetylcysteine (NAC), and coenzyme Q10 have demonstrated antioxidant and anti-inflammatory properties that may improve androgen balance and ovarian performance [18,19].